Literature DB >> 12464388

The Shb adaptor protein causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial cells.

Kristina Holmqvist1, Michael Cross, Debbie Riley, Michael Welsh.   

Abstract

The mechanisms leading to focal adhesion kinase (FAK) activation remain obscure. We have investigated the role of the adaptor protein Shb in cell spreading and the regulation of FAK phosphorylation in immortalised brain endothelial (IBE) cells. Fibroblast growth factor 2 (FGF-2) stimulation lead to a direct association between Shb and FAK, which was mediated by the phosphotyrosine binding (PTB) domain of Shb. IBE cells overexpressing wild-type or R522K Shb (with an inactive Src homology 2 (SH2) domain) displayed increased FAK phosphorylation as well as enhanced spreading when seeded on collagen. FGF-2-induced tyrosine phosphorylation of Shb was dependent upon Src activity but independent of FAK activation. The use of Rat-1 fibroblasts overexpressing a temperature sensitive v-Src (tsLA29) confirmed that active Src enhanced Shb phosphorylation. The data indicate that Shb binds directly to FAK and regulates its phosphorylation leading to enhanced cell spreading in a Src-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12464388     DOI: 10.1016/s0898-6568(02)00076-1

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  12 in total

Review 1.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis.

Authors:  Björn Åkerblom; Guangxiang Zang; Zhen W Zhuang; Gabriela Calounova; Michael Simons; Michael Welsh
Journal:  Mol Oncol       Date:  2012-01-31       Impact factor: 6.603

3.  FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.

Authors:  Jane Reiland; Doty Kempf; Madhuchhanda Roy; Yvonne Denkins; Dario Marchetti
Journal:  Neoplasia       Date:  2006-07       Impact factor: 5.715

Review 4.  Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.

Authors:  Cristiano Sacchetti; Nunzio Bottini
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

5.  The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.

Authors:  Melany J Wagner; Marilyn S Hsiung; Gerald D Gish; Rick D Bagshaw; Sasha A Doodnauth; Mohamed A Soliman; Claus Jørgensen; Monika Tucholska; Robert Rottapel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

6.  Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Authors:  Chad D Walls; Anton Iliuk; Yunpeng Bai; Mu Wang; W Andy Tao; Zhong-Yin Zhang
Journal:  Mol Cell Proteomics       Date:  2013-09-12       Impact factor: 5.911

Review 7.  Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease.

Authors:  Gina A Smith; Gareth W Fearnley; Michael A Harrison; Darren C Tomlinson; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

8.  Effects of HER2 overexpression on cell signaling networks governing proliferation and migration.

Authors:  Alejandro Wolf-Yadlin; Neil Kumar; Yi Zhang; Sampsa Hautaniemi; Muhammad Zaman; Hyung-Do Kim; Viara Grantcharova; Douglas A Lauffenburger; Forest M White
Journal:  Mol Syst Biol       Date:  2006-10-03       Impact factor: 11.429

Review 9.  The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.

Authors:  Gina A Smith; Gareth W Fearnley; Darren C Tomlinson; Michael A Harrison; Sreenivasan Ponnambalam
Journal:  Biosci Rep       Date:  2015-08-18       Impact factor: 3.840

10.  Molecular mechanisms of OLIG2 transcription factor in brain cancer.

Authors:  Igor F Tsigelny; Valentina L Kouznetsova; Nathan Lian; Santosh Kesari
Journal:  Oncotarget       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.